alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice 6577]

# SUMMARY:

                        Notice is hereby given of the following determinations: Pursuant to the authority vested in me by the Act of October 19, 1965 (79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 Stat. 2681,                         *et seq.*; 22 U.S.C. 6501 note,                         *et seq*.), Delegation of Authority No. 234 of October 1, 1999, Delegation of Authority No. 236 of October 19, 1999, as amended, and Delegation of Authority No. 257 of April 15, 2003 [68 FR 19875], I hereby determine that the objects to be included in the exhibition “Pen and Parchment: Drawing in the Middle Ages,” imported from abroad for temporary exhibition within the United States, are of cultural significance. The objects are imported pursuant to loan agreements with the foreign owners or custodians. I also determine that the exhibition or display of the exhibit objects at The Metropolitan Museum of Art, New York, NY, from on or about June 2, 2009, until on or about August 23, 2009, and at possible additional exhibitions or venues yet to be determined, is in the national interest. Public Notice of these Determinations is ordered to be published in the                         **Federal Register**                        .                    

# FOR FURTHER INFORMATION CONTACT:

For further information, including a list of the exhibit objects, contact Julie Simpson, Attorney-Adviser, Office of the Legal Adviser, U.S. Department of State (telephone: (202) 453-8050). The address is U.S. Department of State, SA-44, 301 4th Street, SW., Room 700, Washington, DC 20547-0001.

Dated: April 3, 2009.

C. Miller Crouch,

Acting Assistant Secretary for Educational and  Cultural Affairs, Department of State.

[FR Doc. E9-8254 Filed 4-9-09; 8:45 am]

BILLING CODE 4710-05-P
EXHIBIT
31.1


CERTIFICATION
PURSUANT TO 18 U.S.C. ss. 1350,


AS
ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002





I, David
Robinson, certify that:





1. I have
reviewed this annual report on Form 10-K of Dynamic Alert Limited;





2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this quarterly report;





3. Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;





4. I am
responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and I
have:





a)
            designed
      such disclosure controls and procedures to ensure that material
      information relating to the registrant, including its consolidated
      subsidiaries, is made known to us by others within those entities,
      particularly during the period in which this quarterly report is being
      prepared;





b)
            evaluated
      the effectiveness of the registrant's disclosure controls and procedures
      as of a date within ninety (90) days prior to the filing date of this
      quarterly report (the "Evaluation Date");
and





c)
            presented
      in this report our conclusions about the effectiveness of the disclosure
      controls and procedures based on our evaluation as of the Evaluation
      Date;





5. The
registrant’s other certifying officer and I have disclosed, based on our most
recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
function):





a)
            all
      significant deficiencies in the design or operation of internal controls
      which could adversely affect the registrant's ability to record, process,
      summarize and report financial data and have identified for the
      registrant's auditors any material weaknesses in internal controls;
      and





b)
            any
      fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant's internal
      controls; and





6. The
registrant’s other certifying officer and I have indicated in this report
whether or not there were significant changes in internal controls or in other
factors that could significantly affect internal controls subsequent to the date
of our most recent evaluation, including any corrective actions with regard to
significant deficiencies and material weaknesses.








Date:
October 8, 2009








By:           /s/
David Robinson





David
Robinson


President,
Chief Executive Officer and principal executive officer
Exhibit 32.1

** **

** **

**Certification of CEO andCFO**

**Pursuant to 18 U.S.C.Section 1350,**

**AsAdopted Pursuant to**

**Section 906 of theSarbanes-Oxley Act of 2002**

 

 

 

In connection with theQuarterly Report on Form 10-Q of Davidson Diversified Real Estate II, L.P. (the"Partnership"), for the quarterly period ended March 31, 2009 as filed with theSecurities and Exchange Commission on the date hereof (the "Report"), Steven D.Cordes, as the equivalent of the chief executive officer of the Partnership, andStephen B. Waters, as the equivalent of the chief financial officer of thePartnership, each hereby certifies, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to thebest of his knowledge:

 

(1)   The Reportfully complies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)   Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Partnership.

 

 

 

This certification isfurnished with this Report pursuant to Section 906 of the Sarbanes-Oxley Act of2002 and shall not be deemed filed by the Partnership for purposes of Section 18of the Securities Exchange Act of 1934, asamended.
#### UNITED STATES of America, Plaintiff—Appellee, v. Fletcher Louis OGLETREE, Jr., aka Fletcher Louis Ogletree, Defendant—Appellant.

No. 03-50272.

D.C. No. CR-02-00494-RSWL.

United States Court of Appeals, Ninth Circuit.

Submitted May 10, 2004.*

Decided May 19, 2004.

Ronald L. Cheng, Office of the U.S. Attorney, Los Angeles, CA, Gregory A. Lesser, Office of the U.S. Attorney, Riverside, CA, for Plaintiff-Appellee.

Kathryn A. Young, Federal Public Defender’s Office, Los Angeles, CA, for Defendant-Appellant.

Before CANBY, KOZINSKI and PAEZ, Circuit Judges.

*

This panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

*211MEMORANDUM**

Fletcher Louis Ogletree, Jr. appeals his guilty-plea conviction and 151-month sentence for bank robbery in violation of 18 U.S.C. § 2113(a).

Pursuant to *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), counsel for Ogletree has filed a brief stating there are no grounds for relief, and a motion to withdraw as counsel of record. No supplemental pro se brief or answering brief has been filed.

Our independent review of the record pursuant to *Penson v. Ohio,*488 U.S. 75, 83, 109 S.Ct. 346, 102 L.Ed.2d 300 (1988), discloses no grounds for relief. Counsel’s motion to withdraw is GRANTED and the appeal is AFFIRMED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.
Exhibit 31.2

CERTIFICATION

I, Stephen B. Waters, certify that:

1.

I have reviewed this quarterly report on Form 10-QSB of Davidson Diversified Real Estate II, L.P.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;



4.

The small business issuer's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and have:



(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(b)

Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(c)

Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and



5.

The small business issuer's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions):



(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and



(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting.

Date: November 13, 2007

/s/Stephen B. Waters

Stephen B. Waters

Vice President of Davidson Diversified Properties, Inc., equivalent of the chief financial officer of the Partnership
**Exhibit 23.1** **CONSENT    OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**     We consent to the incorporation by reference in the following    Registration Statements    (1) Form S-8(No. 333-124151)    pertaining to the LifePoint Hospitals, Inc. 1998 Long-Term    Incentive Plan, LifePoint Hospitals, Inc. Employee Stock    Purchase Plan, LifePoint Hospitals, Inc. Management Stock    Purchase Plan, LifePoint Hospitals, Inc. Retirement Plan,    LifePoint Hospitals, Inc. Outside Director’s Stock and    Incentive Compensation Plan;    (2) Form S-4(No. 333-119929),    as amended, pertaining to the joint proxy statement/prospectus    of Lakers Holding Corp. related to LifePoint Hospitals,    Inc.’s merger with Province Healthcare Company; and    (3) Form S-3(No. 333-128279),    as amended, pertaining to the $225,000,000    3.25% Convertible Senior Subordinated Debentures due 2025,    of our reports dated February 6, 2007, with respect to the    consolidated financial statements of LifePoint Hospitals, Inc.,    LifePoint Hospitals, Inc. management’s assessment of the    effectiveness of internal control over financial reporting and    the effectiveness of internal control over financial reporting    of LifePoint Hospitals, Inc., included in this Annual Report    (Form 10-K)    for the year ended December 31, 2006.                                          /s/  Ernst & Young LLP     Nashville, Tennessee    February 6, 2007
Larry PERKINS, Appellant, v. STATE of Florida, Appellee.

No. 4D17-3306

District Court of Appeal of Florida, Fourth District.

[February 1, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

*Affirmed.*
[Federal Register Volume 83, Number 16 (Wednesday, January 24, 2018)]
[Notices]
[Page 3355]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01191]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy And Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Investigator Initiated Program 
Project Applications (P01).
    Date: February 15, 2018.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Julio Aliberti, Ph.D., Scientific Review Officer 
Scientific Review Program DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, 
MSC-9823, Rockville, MD 20852, 301-761-7322, 
<a href="/cdn-cgi/l/email-protection#ceafa2a7acabbcbaa7a4ad8ea0a7afa7aae0a0a7a6e0a9a1b8"><span class="__cf_email__" data-cfemail="395855505b5c4b4d50535a79575058505d17575051175e564f">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Resource-related Research 
Projects (R24).
    Date: February 22, 2018.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer Scientific Review Program, Division of Extramural 
Activities/Room 3G31B, National Institutes of Health, NIAID, 5601 
Fishers Lane MSC 9823, Rockville, MD 20892, (240) 669-5060, 
<a href="/cdn-cgi/l/email-protection#8ae0ebe7eff9a4f9e4f3eeeff8cae4e3e2a4ede5fc"><span class="__cf_email__" data-cfemail="274d464a42540954495e43425567494e4f09404851">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 18, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-01191 Filed 1-23-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 83, Number 16 (Wednesday, January 24, 2018)]
[Notices]
[Pages 3392-3393]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-01203]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


National Research Advisory Council; Notice of Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act (FACA) that the National Research 
Advisory Council will hold a meeting on Wednesday, March 7, 2018, in 
Suite 102, Conference Room C100, at 31 Hopkins Place, Baltimore, MD 
21201. The meeting will convene at 9:00 a.m. and end at 3:30 p.m. This 
meeting is open to the public.
    The agenda will include introduction of newly appointed members, 
annual Ethics and Advisory Committee Management Office training, 
research priorities, service updates, communications update, and 
scientific presentations. No time will be allocated at this meeting for 
receiving oral presentations from the public. Members of the public 
wanting to attend may contact Melissa Cooper, Designated

[[Page 3393]]

Federal Officer, ORD (10P9), Department of Veterans Affairs, 810 
Vermont Avenue NW, Washington, DC 20420, at (202) 461-6044, or by email 
at <a href="/cdn-cgi/l/email-protection#0b466e676278786a254864647b6e794b7d6a256c647d"><span class="__cf_email__" data-cfemail="ce83aba2a7bdbdafe08da1a1beabbc8eb8afe0a9a1b8">[email protected]</span></a> no later than close of business on February 
28, 2018. Because the meeting is being held in a Government building, a 
photo I.D. must be presented at the Guard's Desk as a part of the 
clearance process. Due to security protocols, and in order to prevent 
delays in clearance processing, you should allow an additional 30 
minutes before the meeting begins. Any member of the public seeking 
additional information should contact Melissa Cooper at the phone 
number or email address noted above.

    Dated: January 18, 2018.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2018-01203 Filed 1-23-18; 8:45 am]
BILLING CODE P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### UNITED STATES of America, Appellee, v. Raymond A. POITRA, Appellant.

No. 03-2343.

United States Court of Appeals, Eighth Circuit.

Submitted May 7, 2004.

Decided May 24, 2004.

David L. Peterson, U.S. Attorney’s Office, Bismarck, ND, for Plaintiff-Appellee.

Raymond A. Poitra, Duluth, MN, pro se.

Richard L. Hagar, Kenner Law Firm, Minot, ND, for Defendant-Appellant.

*74Before MELLOY, HANSEN, and COLLOTON, Circuit Judges.

PER CURIAM.

Raymond A. Poitra pleaded guilty to charges relating to his embezzlement .and theft of funds from an Indian tribal organization owned by the Turtle Mountain Band of Chippewa Indians. The district court1 sentenced him to 57 months imprisonment and 2 years supervised release, and ordered restitution of $577,397. Poitra appeals.

The government moves to dismiss on the basis of an appeal waiver contained in the plea agreement. Poitra’s counsel has moved to withdraw and filed a brief under *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), noting the appeal waiver and suggesting that no appealable issues exist. Poitra has filed a pro se supplemental brief raising issues related to his counsel’s effectiveness and the validity of his guilty plea.

We enforce the appeal waiver and grant the government’s motion to dismiss this appeal. *See United States v. Andis,*333 F.3d 886, 889-90 (8th Cir.) (en banc), *cert. denied,*— U.S.-, 124 S.Ct. 501, 157 L.Ed.2d 398 (2003). Having reviewed the record independently under *Penson v. Ohio,*488 U.S. 75, 109 S.Ct. 346, 102 L.Ed.2d 300 (1988), we have found no non-frivolous issues falling outside the scope of the appeal waiver. Accordingly, we grant counsel’s motion to withdraw.

1

. The Honorable Daniel L. Hovland, Chief Judge, United States District Court for the District of North Dakota.
<PAGE>



                                  EXHIBIT 10.2

                                SECOND AMENDMENT
                                       TO
                         EXECUTIVE EMPLOYMENT AGREEMENT


         This Second Amendment to Executive Employment Agreement (this "Second
Amendment") is made to be effective as of May ___, 2005 by and between Daniel D.
Viren ("Executive") and R. G. Barry Corporation (the "Company").

                              W I T N E S S E T H:

         WHEREAS, Executive and the Company are parties to an Executive
Employment Agreement dated June 5, 2000, as amended by that certain First
Amendment to Executive Employment Agreement dated June 5, 2003 (the
"Agreement");

         WHEREAS, the term of the Agreement expires on June 5, 2005;

         WHEREAS, Executive and the Company desire to extend the term of the
Agreement by two years; and

         WHEREAS, such extension of the term of the Agreement has been
recommended by the Compensation Committee and approved by the Board of Directors
of the Company;

         NOW, THEREFORE, in consideration of the premises and for other good and
valuable consideration, the Company and Executive agree as follows:

         1. Section 2 of the Agreement is hereby amended in its entirety to read
as follows:

                  Section 2. Term of Employment. The term of employment of
                  Executive by the Company under this Agreement shall commence
                  on June 5, 2000 (the "Agreement Date") and end on June 5, 2007
                  (the "Term of Employment").

         2. Except as expressly amended hereby, the Agreement, as amended by
this Second Amendment, shall remain in full force and effect.

         3. This Second Amendment may be executed in any number of counterparts,
and each of such counterparts, when so executed, shall be deemed to be an
original and all such counterparts shall together constitute but one and the
same instrument.

         IN WITNESS WHEREOF, the parties hereto have executed this Second
Amendment, to be effective as of the day and year first above written.

                                     R. G. BARRY CORPORATION



                                     By:  /s/ Thomas M. Von Lehman
                                          ------------------------
                                          Thomas M. Von Lehman,
                                          President and Chief Executive Officer


                                          /s/ Daniel D. Viren
                                          -----------------------------------
                                          Daniel D. Viren